Meeting
2020 ASCO Virtual Scientific Program
Targeted DNA sequencing analysis to reveal genetic diversity and androgen-receptor alteration in advanced EGFR mutant lung adenocarcinoma.
Authors
Wei Wu
University of California, San Francisco, San Francisco, CA
Wei Wu , Ross A. Okimoto , Collin Michael Blakely , James Fraser , Trever G. Bivona
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9526)
DOI
10.1200/JCO.2020.38.15_suppl.9526
Abstract #
9526
Poster Bd #
292
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Multi-institutional multiplexed genetic analysis in lung adenocarcinoma (AC): The Lung Cancer Mutation Consortium (LCMC I) experience.
First Author: Dara Aisner
Poster
2014 ASCO Annual Meeting
Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas.
First Author: Juliana Eng
Poster
2018 ASCO Annual Meeting
An explorative phase 2 study of afatinib for advanced cancers carrying an EGFR, a HER2 or a HER3 mutation: A Precision trial of the Belgian Society of Medical Oncology.
First Author: Lore Decoster
Poster
2017 ASCO Annual Meeting
Evolution and clinical impact of genomic alterations detectable in circulating tumor DNA of 1150 advanced EGFR-mutant (mt) lung cancer patients.
First Author: Collin M. Blakely